Atrial Fibrillation is defined as the type of cardiac arrhythmia distinguished by an abnormal heart rhythm due to disturbance in heart’s electrical system. This is considered as the most prevalent types of cardiac arrhythmia. Atrial fibrillation also referred as A-fib or AF. Increase in prevalence of AF with rise in product approvals over this forecast period is expected to drive the market growth.
Increase in prevalence of atrial fibrillation is key driving factor which is expected to boost the global atrial fibrillation market growth. For instance, as per the study “Prevalence of atrial fibrillation in various socioeconomic regions of China and its association with stroke’’ will positively influence the market growth. Furthermore, rise in geriatric population is also propel the market growth during this forecast timeline. For instance, as per the WHO, geriatric population is projected to reach 2 billion by 2050 from 900 million in 2015. Also, increase in technological advancements will fuel the market growth during this forecast period. In addition to that, rise in adoption of closure devices for the treatment of atrial fibrillation is expected to support the global atrial fibrillation market growth. The increase in research and development activities expected to offer lucrative growth opportunities to market in near future.
High cost of atrial fibrillation treatment incurred by the patient is major restraint which is expected to limit the global atrial fibrillation market growth. Further, product recall and stringent product approval regulations will hinder the market growth. For instance, in 2019, Medtronic received Food and Drug Administration recall for implemented cardiac pacemakers from market. In addition to that, lack of skilled professionals will hamper the market growth.
Global Atrial Fibrillation Market is segmented on the basis of procedure such as Pharmacological (Anti-arrhythmic and Anti-coagulant), and Non-pharmacological (Catheter Ablation Procedures, Maze Surgery, and Electric Cardio version).
Further, Global Atrial Fibrillation Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
By Region North America Latin America Europe Asia Pacific Middle East & Africa
Key Questions Addressed by the Report What are the Key Opportunities in Global Atrial Fibrillation Market? What will be the growth rate from 2019 to 2030? Which segment/region will have highest growth? What are the factors that will impact/drive the Market? What is the competitive Landscape in the Industry? What is the role of key players in the value chain? What are the strategies adopted by key players?
1 Introduction 1.1 Objective of the Study 1.2 Market definition 1.3 Market Scope
2 Research Methodology
2.1 Data Mining 2.2 Validation 2.3 Primary Interviews 2.4 List of Data Sources
3 Executive Summary 4 Global Atrial Fibrillation Market Outlook 4.1 Overview 4.2 Market Dynamics 4.2.1 Drivers 4.2.2 Restraints 4.2.3 Opportunities 4.3 Porters Five Force Model 4.4 Value Chain Analysis
5 Global Atrial Fibrillation Market, By Procedure 5.1 Y-o-Y Growth Comparison, By Procedure
5.2 Global Atrial Fibrillation Market Share Analysis, By Procedure
5.3 Global Atrial Fibrillation Market Size and Forecast, By Procedure 5.3.1 Pharmacological
5.3.1.1 Anti-arrhythmic
5.3.1.2 Anti-coagulant
5.3.2 Non-Pharmacological
5.3.2.1 Catheter Ablation Procedures
5.3.2.2 Maze Surgery
5.3.2.3 Electric Cardio version
6Global Atrial Fibrillation Market, By Region 6.1 Global Atrial Fibrillation Market Share Analysis, By Region
6.2 Global Atrial Fibrillation Market Share Analysis, By Region
6.3 Global Atrial Fibrillation Market Size and Forecast, By Region
7North America Atrial Fibrillation Market Analysis and Forecast (2020 – 2027) 7.1 Introduction
7.2 North America Atrial Fibrillation Market Share Analysis, By Procedure
7.3 North America Atrial Fibrillation Market Size and Forecast, By Application
7.4 North America Atrial Fibrillation Market Size and Forecast, By Country
7.4.1 U.S 7.4.2 Canada 7.4.3 Mexico
8Europe Atrial Fibrillation Market Analysis and Forecast (2020 – 2030) 8.1 Introduction
8.2 Europe Atrial Fibrillation Market Share Analysis, By Procedure
8.3 Europe Atrial Fibrillation Market Size and Forecast, By Application
8.4 Europe Atrial Fibrillation Market Size and Forecast, By Country
8.4.1 Germany 8.4.2 France 8.4.3 UK
8.4.4. Rest of Europe
9Asia Pacific Atrial Fibrillation Market Analysis and Forecast (2020 – 2030) 9.1 Introduction
9.2 Asia Pacific Atrial Fibrillation Market Share Analysis, By Procedure
9.3 Asia Pacific Atrial Fibrillation Market Size and Forecast, By Application
9.4 Asia Pacific Atrial Fibrillation Market Size and Forecast, By Country
9.4.1 China 9.4.2 Japan 9.4.3 India
9.4.4. Rest of Asia Pacific
10Latin America Atrial Fibrillation Market Analysis and Forecast (2020 – 2030) 10.1 Introduction
10.2 Latin America Atrial Fibrillation Market Share Analysis, By Procedure
10.3 Latin America Atrial Fibrillation Market Size and Forecast, By Application
10.4 Latin America Atrial Fibrillation Market Size and Forecast, By Country
11Middle East Atrial Fibrillation Market Analysis and Forecast (2020 – 2030) 11.1 Introduction
11.2 Middle East Atrial Fibrillation Market Share Analysis, By Procedure
11.3 Middle East Atrial Fibrillation Market Size and Forecast, By Application
11.4 Middle East Atrial Fibrillation Market Size and Forecast, By Country
12Competitive Analysis 12.1 Competition Dashboard 12.2 Market share Analysis of Top Vendors 12.3 Key Development Strategies
13Company Profiles
13.1 Abbott Laboratories 13.1.1 Overview 13.1.2 Offerings 13.1.3 Key Financials 13.1.4 Business Segment & Geographic Overview
13.1.5 Key Market Developments
13.1.6 Key Strategies
13.2 AtriCure Inc
13.2.1 Overview 13.2.2 Offerings 13.2.3 Key Financials 13.2.4 Business Segment & Geographic Overview
13.2.5 Key Market Developments
13.2.6 Key Strategies
13.3 Siemens AG
13.3.1 Overview 13.3.2 Offerings 13.3.3 Key Financials 13.3.4 Business Segment & Geographic Overview
13.3.5 Key Market Developments
13.3.6 Key Strategies
13.4 Koninklijke Philips N.V 13.4.1 Overview 13.4.2 Offerings 13.4.3 Key Financials 13.4.4 Business Segment & Geographic Overview
13.4.5 Key Market Developments
13.4.6 Key Strategies
13.5 Biotronik SE & Co. KG 13.5.1 Overview 13.5.2 Offerings 13.5.3 Key Financials 13.5.4 Business Segment & Geographic Overview
13.5.5 Key Market Developments
13.5.6 Key Strategies
13.6 Medtronic plc 13.6.1 Overview 13.6.2 Offerings 13.6.3 Key Financials 13.6.4 Business Segment & Geographic Overview
13.6.5 Key Market Developments
13.6.6 Key Strategies
13.7 St. Jude Medical Inc 13.7.1 Overview 13.7.2 Offerings 13.7.3 Key Financials 13.7.4 Business Segment & Geographic Overview
13.7.5 Key Market Developments
13.7.6 Key Strategies
13.8 Boston Scientific Corporation
13.8.1 Overview 13.8.2 Offerings 13.8.3 Key Financials 13.8.4 Business Segment & Geographic Overview
13.8.5 Key Market Developments
13.8.6 Key Strategies
13.9 MicroPort Scientific Corporation
13.9.1 Overview 13.9.2 Offerings 13.9.3 Key Financials 13.9.4 Business Segment & Geographic Overview
13.9.5 Key Market Developments
13.9.6 Key Strategies
13.10 Johnson & Johnson
13.10.1 Overview 13.10.2 Offerings 13.10.3 Key Financials 13.10.4 Business Segment & Geographic Overview
13.10.5 Key Market Developments
13.10.6 Key Strategies
